Please login to the form below

23

Revenue 2017

Teva

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Teva's 2013 sales performance.

AstraZeneca chief on Brexit: “it’s going to be really painful”

That disparity – which Soriot says is “annoying” - may be a reason for the rumour last year that he was planning to jump ship to Teva, which he dismisses in the interview ... Teva’s vacant CEO role eventually filled by Lundbeck’s Kåre Schultz.

New Awards scheme for medical and scientific professionals

Demand for this new initiative has been strong – with entries / nominations from Novo Nordisk, BMS, Eisai, GSK, Shire, Gilead, Lundbeck, Bayer, Boehringer, Teva and more.

Gilead and ViiV among winners at PM Society Digital Awards

Meanwhile ViiV Healthcare, Teva and Celgene all took a Gold and a Silver.

Teva wins FDA OK for crucial migraine drug

Teva wins FDA OK for crucial migraine drug. Vital to Teva's turnaround, Ajovy will challenge Novartis/Amgen's Aimovig. ... Teva has secured US approval for migraine drug Ajovy, a key part of new chief execeutive Kåre Schultz's turnaround plan for the

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 (Next 4)

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology

Featured jobs

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Senior Medical Writer: Salary is DOE

Associate Scientific Director: Salary TBC

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Senior Writer, Healthcare Advertising, London: Excellent package

Account Manager- 4 days per week or full-time: Salary TBC

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Graduate Scientific Editor: DOE

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Healthcare Advertising Account Manager / Senior AM / AD: Salary TBC

Account Manager: Negotiable

Market Access Consultant - Greater Manchester: Negotiable

Healthcare PR Senior Account Manager: Salary TBC

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Senior Account Manager – Healthcare Advertising: Salary TBC

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Account Director - Digital: Great salary and benefits

Medical Writer - Creative and Scientific Projects: DOE

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Senior Account Manager / Account Director - Med Comms: Great salary and benefits

Account Director, Healthcare Advertising Agency: Salary TBC

Healthcare PR Director: £100, 000 – £120, 000 benefits

Solaris Health looks at the gene therapy revolution: Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...